ÂÜÀòÂÒÂ×

Mr. Peisert has served as President, Chief Executive Officer, and Director of Assertio since December 2020. Mr. Peisert joined Assertio as Vice President, Business Development in September 2017 and previously held the roles of Senior Vice President, Business Development and Senior Vice President and Chief Financial Officer for the company.

Most recently he served in the position of Vice President of Concordia International Corp.’s US Legacy Pharmaceuticals business where he had full P&L responsibility for the business unit. Prior to this, he was Vice President, Business Development for Concordia and was responsible for executing on the strategic M&A plan. Previously, Mr. Peisert was Director, Finance and Business Development for Marathon Pharmaceuticals, a privately held specialty pharmaceutical company.

Prior to entering the pharmaceutical industry, he was a healthcare Equity Analyst and for Magnetar Capital and a Portfolio Manager for UBS O’Connor and began his career as an Auditor for Price Waterhouse Coopers.

Mr. Peisert holds a bachelor’s degree in business with an emphasis on accounting from the University of Minnesota.